Facilitation of I Kr current by some hERG channel blockers suppresses early afterdepolarizations

Kazuharu Furutani, Kunichika Tsumoto, I. Shan Chen, Kenichiro Handa, Yuko Yamakawa, Jon T Sack, Yoshihisa Kurachi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Drug-induced block of the cardiac rapid delayed rectifying potassium current (IKr), carried by the human ether-a-go-gorelated gene (hERG) channel, is the most common cause of acquired long QT syndrome. Indeed, some, but not all, drugs that block hERG channels cause fatal cardiac arrhythmias. However, there is no clear method to distinguish between drugs that cause deadly arrhythmias and those that are clinically safe. Here we propose a mechanism that could explain why certain clinically used hERG blockers are less proarrhythmic than others. We demonstrate that several drugs that block hERG channels, but have favorable cardiac safety profiles, also evoke another effect; they facilitate the hERG current amplitude in response to low-voltage depolarization. To investigate how hERG facilitation impacts cardiac safety, we develop computational models of I Kr block with and without this facilitation. We constrain the models using data from voltage clamp recordings of hERG block and facilitation by nifekalant, a safe class III antiarrhythmic agent. Human ventricular action potential simulations demonstrate the ability of nifekalant to suppress ectopic excitations, with or without facilitation. Without facilitation, excessive I Kr block evokes early afterdepolarizations, which cause lethal arrhythmias. When facilitation is introduced, early afterdepolarizations are prevented at the same degree of block. Facilitation appears to prevent early afterdepolarizations by increasing I Kr during the repolarization phase of action potentials. We empirically test this prediction in isolated rabbit ventricular myocytes and find that action potential prolongation with nifekalant is less likely to induce early afterdepolarization than action potential prolongation with dofetilide, a hERG channel blocker that does not induce facilitation. Our data suggest that hERG channel blockers that induce facilitation increase the repolarization reserve of cardiac myocytes, rendering them less likely to trigger lethal ventricular arrhythmias.

Original languageEnglish (US)
Pages (from-to)214-230
Number of pages17
JournalJournal of General Physiology
Volume151
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Ether
Genes
Action Potentials
Cardiac Arrhythmias
Pharmaceutical Preparations
Safety
Long QT Syndrome
Cardiac Myocytes
Muscle Cells
Potassium
Rabbits

ASJC Scopus subject areas

  • Physiology

Cite this

Facilitation of I Kr current by some hERG channel blockers suppresses early afterdepolarizations . / Furutani, Kazuharu; Tsumoto, Kunichika; Chen, I. Shan; Handa, Kenichiro; Yamakawa, Yuko; Sack, Jon T; Kurachi, Yoshihisa.

In: Journal of General Physiology, Vol. 151, No. 2, 01.02.2019, p. 214-230.

Research output: Contribution to journalArticle

Furutani, Kazuharu ; Tsumoto, Kunichika ; Chen, I. Shan ; Handa, Kenichiro ; Yamakawa, Yuko ; Sack, Jon T ; Kurachi, Yoshihisa. / Facilitation of I Kr current by some hERG channel blockers suppresses early afterdepolarizations In: Journal of General Physiology. 2019 ; Vol. 151, No. 2. pp. 214-230.
@article{3eabe7a599be4276a0e5482c4a962367,
title = "Facilitation of I Kr current by some hERG channel blockers suppresses early afterdepolarizations",
abstract = "Drug-induced block of the cardiac rapid delayed rectifying potassium current (IKr), carried by the human ether-a-go-gorelated gene (hERG) channel, is the most common cause of acquired long QT syndrome. Indeed, some, but not all, drugs that block hERG channels cause fatal cardiac arrhythmias. However, there is no clear method to distinguish between drugs that cause deadly arrhythmias and those that are clinically safe. Here we propose a mechanism that could explain why certain clinically used hERG blockers are less proarrhythmic than others. We demonstrate that several drugs that block hERG channels, but have favorable cardiac safety profiles, also evoke another effect; they facilitate the hERG current amplitude in response to low-voltage depolarization. To investigate how hERG facilitation impacts cardiac safety, we develop computational models of I Kr block with and without this facilitation. We constrain the models using data from voltage clamp recordings of hERG block and facilitation by nifekalant, a safe class III antiarrhythmic agent. Human ventricular action potential simulations demonstrate the ability of nifekalant to suppress ectopic excitations, with or without facilitation. Without facilitation, excessive I Kr block evokes early afterdepolarizations, which cause lethal arrhythmias. When facilitation is introduced, early afterdepolarizations are prevented at the same degree of block. Facilitation appears to prevent early afterdepolarizations by increasing I Kr during the repolarization phase of action potentials. We empirically test this prediction in isolated rabbit ventricular myocytes and find that action potential prolongation with nifekalant is less likely to induce early afterdepolarization than action potential prolongation with dofetilide, a hERG channel blocker that does not induce facilitation. Our data suggest that hERG channel blockers that induce facilitation increase the repolarization reserve of cardiac myocytes, rendering them less likely to trigger lethal ventricular arrhythmias.",
author = "Kazuharu Furutani and Kunichika Tsumoto and Chen, {I. Shan} and Kenichiro Handa and Yuko Yamakawa and Sack, {Jon T} and Yoshihisa Kurachi",
year = "2019",
month = "2",
day = "1",
doi = "10.1085/jgp.201812192",
language = "English (US)",
volume = "151",
pages = "214--230",
journal = "Journal of General Physiology",
issn = "0022-1295",
publisher = "Rockefeller University Press",
number = "2",

}

TY - JOUR

T1 - Facilitation of I Kr current by some hERG channel blockers suppresses early afterdepolarizations

AU - Furutani, Kazuharu

AU - Tsumoto, Kunichika

AU - Chen, I. Shan

AU - Handa, Kenichiro

AU - Yamakawa, Yuko

AU - Sack, Jon T

AU - Kurachi, Yoshihisa

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Drug-induced block of the cardiac rapid delayed rectifying potassium current (IKr), carried by the human ether-a-go-gorelated gene (hERG) channel, is the most common cause of acquired long QT syndrome. Indeed, some, but not all, drugs that block hERG channels cause fatal cardiac arrhythmias. However, there is no clear method to distinguish between drugs that cause deadly arrhythmias and those that are clinically safe. Here we propose a mechanism that could explain why certain clinically used hERG blockers are less proarrhythmic than others. We demonstrate that several drugs that block hERG channels, but have favorable cardiac safety profiles, also evoke another effect; they facilitate the hERG current amplitude in response to low-voltage depolarization. To investigate how hERG facilitation impacts cardiac safety, we develop computational models of I Kr block with and without this facilitation. We constrain the models using data from voltage clamp recordings of hERG block and facilitation by nifekalant, a safe class III antiarrhythmic agent. Human ventricular action potential simulations demonstrate the ability of nifekalant to suppress ectopic excitations, with or without facilitation. Without facilitation, excessive I Kr block evokes early afterdepolarizations, which cause lethal arrhythmias. When facilitation is introduced, early afterdepolarizations are prevented at the same degree of block. Facilitation appears to prevent early afterdepolarizations by increasing I Kr during the repolarization phase of action potentials. We empirically test this prediction in isolated rabbit ventricular myocytes and find that action potential prolongation with nifekalant is less likely to induce early afterdepolarization than action potential prolongation with dofetilide, a hERG channel blocker that does not induce facilitation. Our data suggest that hERG channel blockers that induce facilitation increase the repolarization reserve of cardiac myocytes, rendering them less likely to trigger lethal ventricular arrhythmias.

AB - Drug-induced block of the cardiac rapid delayed rectifying potassium current (IKr), carried by the human ether-a-go-gorelated gene (hERG) channel, is the most common cause of acquired long QT syndrome. Indeed, some, but not all, drugs that block hERG channels cause fatal cardiac arrhythmias. However, there is no clear method to distinguish between drugs that cause deadly arrhythmias and those that are clinically safe. Here we propose a mechanism that could explain why certain clinically used hERG blockers are less proarrhythmic than others. We demonstrate that several drugs that block hERG channels, but have favorable cardiac safety profiles, also evoke another effect; they facilitate the hERG current amplitude in response to low-voltage depolarization. To investigate how hERG facilitation impacts cardiac safety, we develop computational models of I Kr block with and without this facilitation. We constrain the models using data from voltage clamp recordings of hERG block and facilitation by nifekalant, a safe class III antiarrhythmic agent. Human ventricular action potential simulations demonstrate the ability of nifekalant to suppress ectopic excitations, with or without facilitation. Without facilitation, excessive I Kr block evokes early afterdepolarizations, which cause lethal arrhythmias. When facilitation is introduced, early afterdepolarizations are prevented at the same degree of block. Facilitation appears to prevent early afterdepolarizations by increasing I Kr during the repolarization phase of action potentials. We empirically test this prediction in isolated rabbit ventricular myocytes and find that action potential prolongation with nifekalant is less likely to induce early afterdepolarization than action potential prolongation with dofetilide, a hERG channel blocker that does not induce facilitation. Our data suggest that hERG channel blockers that induce facilitation increase the repolarization reserve of cardiac myocytes, rendering them less likely to trigger lethal ventricular arrhythmias.

UR - http://www.scopus.com/inward/record.url?scp=85061127623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061127623&partnerID=8YFLogxK

U2 - 10.1085/jgp.201812192

DO - 10.1085/jgp.201812192

M3 - Article

C2 - 30674563

AN - SCOPUS:85061127623

VL - 151

SP - 214

EP - 230

JO - Journal of General Physiology

JF - Journal of General Physiology

SN - 0022-1295

IS - 2

ER -